Listing Date Delayed for Capital Increase
EDGC
245620
Signal Score
Historical Avg Return (5d)
+0.15%
Data Coverage
100%n=2535
Risk-adjusted indicator based on 2535 historical DART filings. For informational purposes only — not investment advice.
Financial Impact
NEUTRAL
Key Numbers
- • Previous Listing Date: June 2, 2026
- • Revised Listing Date: June 12, 2026
- • Board Resolution Date: March 20, 2026 (Court Approval)
- • Capital Increase Type: Third-party allocation for debt-to-equity conversion
AI Analysis Summary
Eone Diagnomics Genome Center Co., Ltd. announced an amendment to its Material Fact Report regarding a paid-in capital increase. The new shares' listing date has been delayed from June 2, 2026, to June 12, 2026, due to practical procedures with the Korea Securities Depository. This capital increase is a third-party allocation for debt-to-equity conversion, part of a court-approved rehabilitation plan from March 20, 2026. No new cash payment is involved, as it converts existing debt into equity. The change is procedural, with no direct impact on the company's financial standing or operational outlook.
How This Event Is Evaluated
Capital Raise Evaluation
Capital raise events are evaluated by estimating dilution pressure, funding purpose, pricing terms, and impact on existing shareholders.
AI is used to interpret disclosures and extract structured data.
Signal scores are generated using event-specific methodologies and quantitative models.
- Potential dilution rate
- Issuance or conversion price
- Funding purpose
- Shareholder value impact
Track Korean Market Signals — Free
Sign up free to access live disclosures, AI analysis, and event filters.
Public Beta · No credit card required
This content is for informational purposes only and does not constitute investment advice. Past signal patterns do not guarantee future results. All data is sourced from public DART filings.